Abstract: As part of our ongoing alternative medicine program, we have directed our attention toward the identification of edible seaweeds in Korea. Here we report on the anti-inflammatory activities of Ecklonia stolonifera. The present study was undertaken to elucidate the pharmacological and biological effects of E. stolonifera extracts on the production of inflammatory mediators in macrophages. The results indicate that the hexane fraction of E. stolonifera extract (ESH) is an effective inhibitor of lipopolysccharide (LPS)-induced NO, prostaglandin E2, and proinflammatory cytokine production in RAW 264.7 cells. These inhibitory effects of ESH were accompanied by decreases in the expression of inducible nitric oxide synthase and cyclooxygenase-2 proteins. Furthermore, ESH inhibited the LPS-induced phosphorylation and degradation of IκB-α, which is required for the nuclear translocations of the p50 and p65 nuclear transcription factor kappa-B (NF-κB) subunits in RAW 264.7 cells. Our results suggest that ESH might exert an anti-inflammatory effect by inhibiting the expression of pro-inflammatory cytokines. Such an effect is mediated by a blocking of NF-κB activation, which consequently inhibits the generation of inflammatory mediators in RAW264.7 cells. Through HPLC fingerprinting of the E. stolonifera extract, the phloroglucinol was also identified and quantified as standard substance. Moreover, we tested the potential application of E. stolonifera extract as a cosmetic material by performing human skin primary irritation tests. In these assays, E. stolonifera extracts did not induce any adverse reactions. Based on these results, we suggest that E. stolonifera extracts be considered possible anti-inflammatory candidates for topical application.
Introduction
Ecklonia stolonifera Okamura is a perennial brown marine alga that belongs to the family Laminariaceae. This species is usually found in sub-tidal zones at depths between 2 and 10 m, and is widely distributed throughout the eastern and southern coasts of Korea. Four Ecklonia species, E. stolonifera Okamura, Ecklonia cava Kjellman, Eisenia bicyclis (Kjellman) Setchell, and Ecklonia kurome Okamura, are found in Korea. Of the Ecklonia sp., Ecklonia stolonifera, called Gom-Pee in Korean, is often used as a foodstuff. It has been previously reported that E. stolonifera harbors several bio-active compounds, including fucosterol, 24-hydroperoxy 24-vinylcholesterol, phloroglucinol, eckstolonol, eckol, phlorofucofuroeckol-A, dieckol, triphlorethol-A, 2-phloroeckol and 7-phloroeckol, which function as antioxidants . This algae has also been shown to exhibit angiotensin-converting enzyme I inhibitory activity (Jung et al. 2006) , total reactive oxygen species generation inhibitory activity (Kang et al. 2004a) , aldose reductase inhibitory activity (Jung et al. 2008) , antidiabetic, antioxidant and anti-hyperlipidemic effects (Lee et al. 1996; , hepatoprotective activity , inhibitory effects on MMP-1 expression (Joe et al. 2006 ), anti-tyrosinase activity (Kang et al. 2004b) , and acetyland butyryl-cholinesterase inhibitory activities . Additionally, several researchers have studied the antimicrobial effects of phloroglucinol derivatives . In particular, phloroglucinol polymers, including dieckol, 8,8'-bieckol, and phloro-furofucoeckol A, have been reported to show marked bactericidal effects against methicillin-resistant Staphylococcus aureus . However, the antiinflammatory effect of E. stolonifera extract has not been reported until now. Therefore, we conducted a detailed study to investigate the anti-inflammatory effects of E. stolonifera extract in RAW 264.7 cells.
Seaweed-derived anti-inflammatory compounds have been investigated for their potential inhibitory effects in vitro using lipopolysaccharide (LPS)-stimulated macrophages. In this system, bacterial LPS is one of the best-characterized stimuli used to induce upregulation of pro-inflammatory proteins such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). Inducible COX-2 is responsible for the high prostaglandin levels observed in many inflammatory pathologies (Simmons et al. 2004) . Similarly, iNOS produces large amounts of NO and is thought to play a central role in inflammatory disease.
Nuclear transcription factor kappa-B (NF-κB) regulates various genes involved in immune and acute phase inflammatory responses. NF-κB activation, in response to pro-inflammatory stimuli, involves the rapid phosphorylation of inhibitors of kappa-B (IκBs) by the IκB kinase (IKK) signalosome complex. Free NF-κB produced by this process translocates to the nucleus, where it binds to κB-binding sites in the promoter regions of target genes. It then induces the transcription of pro-inflammatory mediators such as iNOS, COX-2, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-8 (Ghosh & Hayden 2008; Edwards et al. 2009; Wong & Tergaonkar 2009) . Therefore, the present study was focused on whether the hexane fraction from E. stolonifera extract (ESH) inhibited NF-κB activation in LPS-stimulated macrophages. We also performed primary human skin irritation tests.
Material and methods

Reagents
Dulbecco's modified Eagle's medium and fetal bovine serum were purchased from Hyclone (Logan, UT, USA). LPS (E. coli 0111:B4) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). All other chemicals used were Sigma grade. The enzyme-linked immunosorbent assay (ELISA) kit for prostaglandin E2 (PGE2) was obtained from R&D Systems, Inc. (Minneapolis, MN, USA), and TNF-α and IL-6 were obtained from BD Biosciences (San Diego, CA, USA). Antibody against iNOS was purchased from Calbiochem (San Diego, CA, USA) and antibodies against COX-2, NF-κB (p65), phospho NF-κB (p65) and IκB-α were from Cell Signaling Technology (Beverly, MA, USA).
Materials and solvent extraction E. stolonifera were collected from Busan, Korea (in October 2006) . Voucher specimen number A07-0000074 is deposited at the herbarium of Jeju Biodiversity Research Institute. The materials for extraction were cleaned, dried at room temperature for 2 weeks and ground into a fine powder using a blender. The dried powder (20 g) was extracted with 80% ethanol (EtOH; 2 L) at room temperature for 24 h and then evaporated under vacuum. The evaporated EtOH extract (10 g) was suspended in water (1 L) and fractionated with four solvents: n-hexane (1 L), dichloromethane (CH2Cl2; 1 L), ethyl acetate (EtOAc; 1 L), and butanol (BuOH; 1 L). The yield and recovery of these five solvent fractions were as follows: n-hexane (0.2 g, 2.0%), CH2Cl2 (0.7 g, 7.0%), EtOAc (1.0 g, 10.0%), BuOH (1.9 g, 19.0%) and H2O (6.2 g, 62.0%).
Cell culture
Murine macrophage RAW 264.7 cells were purchased from the Korean Cell Line Bank (Seoul, Korea). They were cultured in Dulbecco's modified Eagle's medium containing 2 mM glutamine, 10 mM HEPES, penicillin (100 units/mL), streptomycin (100 µg/mL) and 10% fetal bovine serum. Cells were cultured at 37
• C in a humidified incubator with an atmosphere of 5% CO2.
MTT assay for cell viability Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. RAW 264.7 cells were cultured in 96-well plates for 18 h, followed by treatment with LPS (1 µg/mL) in the presence of various concentrations (12.5, 25, 50, 100 µg/mL) of E. stolonifera. After 24-h incubation, MTT was added to the medium for 4 h. Finally, the supernatant was removed and the formazan crystals were dissolved in DMSO. Absorbance was measured at 540 nm. Percent of cells showing cytotoxicity was determined relative to the control group (Gerlier & Thomasser 1986; Liu 1999) .
NO assay
Nitrite accumulation was measured with Griess reagent as an indicator of NO production in the cell culture medium. The culture supernatant (100 µL) was mixed with an equal volume of Griess reagent (1% sulfanilamide and 0.1% N-[1-naphthyl]-ethylenediamine dihydrochloride in 5% phosphoric acid) for 10 min, and the absorbance was measured at 540 nm (Snell et al. 1996; Woo et al. 2005 ).
Measurement of pro-inflammatory cytokine (TNF-α, IL-6 and IL-1β) production The inhibitory effect of E. stolonifera on TNF-α, IL-6 and IL-1β production in LPS-treated RAW264.7 cells was determined as previously described. Supernatants were then harvested and assayed for cytokines by ELISA (Cho et al. 2000) .
Western blot analysis
After incubation, the cells were washed twice with cold PBS. Whole cell lysates (30 µg) were separated by 8∼12% SDS-PAGE and electro-transferred to polyvinylidene fluoride membrane (Bio-Rad, HC, USA). The membrane was incubated for 2 h with TTBS containing 1% bovine serum albumin, and then incubated with a specific primary antibody at 4
• C overnight. The membrane was washed 4 times with TTBS and incubated for 30 min with peroxidase-conjugated secondary antibody at room temperature. Finally, immunoreactive proteins were detected using the WEST-ZOL Western Blot Detection System (iNtRON, Gyeonggi, Korea). Fig. 1 . Effect of solvent fractions from E. stolonifera on NO production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 µg/mL of LPS only or with LPS plus E. stolonifera (100 µg/mL) for 24 h. NO production was determined by the Griess reagent method. Cell viability was determined after 24 h culture of cells stimulated with LPS (1 µg/mL) in the presence of E. stolonifera. The data represent the mean ± SD of triplicate experiments. *P < 0.05, **P < 0.01 versus LPS alone.
Human skin primary irritation test
On the basis of inclusion and exclusion criteria, 32 healthy female Korean subjects were selected and written consent was obtained in each case. Their average age was 39.94±6.81 years (range: 20-49). The subjects had no history of allergic contact dermatitis, and they had not used topical or systemic irritant preparations in the previous 1 month. An IQ Ultra Chamber was secured to the back of each subject with micropore tape. The round border of the chamber was placed firmly against the skin, causing tight occlusion of the test materials. The 80% EtOH extract of E. stolonifera formulated with squalane was prepared as the negative control and applied at 1% concentration. The patches (chambers) remained in place for 48 h. During this time, the subjects abstained from showering or performing any work or exercise that might wet or loosen the patches. The sites were read 30 min and 24 h after the patches were removed; the readings were scored according to the Cosmetic, Toiletry, and Fragrance Association guidelines.
HPLC fingerprint of E. stolonifera ethanol extract Since phloroglucinol and its derivatives had been reported as effective anti-inflammatory components from the plant, we searched for phloroglucinol in the 80% ethanolic extract of E. stolonifera. The chromatographic analysis of E. stolonifera ethanolic extract was performed using a HPLC with an Alliance TM Waters 2695 separation module coupled to a Waters 2998 photodiode array detector, utilizing a Capcell pak 4.6 mm × 250 mm C18 column (Particle size 5 µ, Shiseido Chemicals, Tokyo, Japan) at a flow rate of 1.0 mL/min. The column was placed in a column oven at 25
Statistical analysis
Results are expressed as mean ± standard error of at least triplicate experiments. Student's t-test was used to assess the statistical significance of differences. P-values of less than 0.05 were considered statistically significant.
Results
Effect of E. stolonifera extracts on NO synthesis in activated macrophages To investigate the effect of E. stolonifera on NO production, we measured the accumulation of nitrite, a stable oxidized product of NO, in the culture media of RAW264.7 cells stimulated with LPS in the presence or absence of E. stolonifera extracts for 24 h. The Griess assay, a spectrophotometric method for determining nitrite, was used to quantify the nitrite levels in the conditioned medium of RAW264.7 cells treated with LPS. Nitrite levels in LPS-stimulated cells increased significantly compared to that in control cells. To evaluate whether extracts of E. stolonifera could modulate NO production by activated macrophages, we examined the effects of the hexane, CH 2 Cl 2 , EtOAc, BuOH, and water fractions of E. stolonifera on NO production in the murine macrophage cell line RAW264.7.
As shown in Figure 1 , among the five fractions, the hexane extract (100 µg/mL) markedly inhibited LPSinduced NO production in RAW264.7 cells by 75.3%. The CH 2 Cl 2 and EtOAc fractions also inhibited LPSinduced production of NO by 68.5% and 45.9%, respectively. There was no basal NO production when cells were incubated with only the crude extract (80% EtOH) from E. stolonifera without LPS (data not shown). The numbers of viable activated macrophages were not altered by the hexane, CH 2 Cl 2 , and EtOAc fractions as determined by MTT assays, indicating that the inhibition of NO production by the hexane, CH 2 Cl 2 , and EtOAc fractions was not simply due to cytotoxic effects.
Effect of E. stolonifera on PGE 2 production in LPSinduced RAW264.7 cells PGE 2 is an inflammatory mediator that is produced from the conversion of arachidonic acid by cyclooxygenase. In a variety of inflammatory cells, including macrophages, COX-2 is induced by cytokines and other activators, such as LPS, resulting in the release of a large amount of PGE 2 at inflammatory sites. Therefore, we next examined the effects of E. stolonifera on PGE 2 production in LPS-stimulated RAW264.7 macrophages. When macrophages were stimulated with LPS (1 µg/mL) for 24 h, the levels of PGE 2 increased in the culture medium. As shown in Figure 2 , 100 µg/mL Fig. 2 . Effect of solvent fractions from E. stolonifera on PGE 2 production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 µg/mL of LPS only or with LPS plus E. stolonifera extracts (100 µg/mL) for 24 h. PGE 2 produced and released into the culture medium was measured by ELISA. The data represent the mean ± SD of triplicate experiments. *P < 0.05, **P < 0.01 versus LPS alone. Fig. 3 . Effect of solvent fractions from E. stolonifera on TNF-α production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 µg/mL of LPS only or with LPS plus E. stolonifera (100 µg/mL) for 24 h. TNF-α produced and released into the culture medium was assayed by ELISA. The data represent the mean ± SD of triplicate experiments. *P < 0.05, **P < 0.01 versus LPS alone.
of the hexane, CH 2 Cl 2 , EtOAc, and BuOH fractions suppressed LPS-induced PGE 2 production by 94.6%, 79.7%, 91.9% and 39.4%, respectively.
Effects of E. stolonifera on LPS-induced TNF-α production TNF-α is mainly produced by activated monocytes or macrophages. Since E. stolonifera potently inhibited the pro-inflammatory mediators, we further investigated its effects on LPS-induced TNF-α release by enzyme immunoassay. After 24-h incubation with both LPS (1 µg/mL) and solvent fractions of E. stolonifera (100 µg/mL), there was remarkable inhibition of TNF-α production (Fig. 3 ) in RAW264.7 cells, especially with the n-hexane and CH 2 Cl 2 fractions.
Effects of ESH on pro-inflammatory cytokines, NO, and PGE 2 production in RAW264.7 cells The potential anti-inflammatory properties of ESH were investigated using RAW 264.7 murine macrophage cells, which can produce NO and PGE 2 upon stimulation with LPS. Cells were pre-incubated with ESH for 1 h, following which they were stimulated with 1 µg/mL LPS for 24 h. Both LPS and sample were not treated in control group. Cell culture media were collected and nitrite and PGE 2 levels determined. ESH was found to inhibit dose-dependently the production of both NO (Fig. 4) and PGE 2 (Fig. 5) . The potential cytotoxicity of ESH was evaluated by MTT assay after incubating cells for 24 h in the absence and presence of LPS. However, cell viability was negligibly affected at the concentrations used (12.5, 25, 50, and 100 µg/mL) to inhibit NO and PGE 2 (Fig. 4) . Thus, the inhibitory effects of ESH were not attributable to cytotoxicity. Western blot analyses were also performed to determine whether the inhibitory effects of ESH on the pro-inflammatory mediators NO and PGE 2 were related to a modulation of iNOS and COX-2 expression. We did not detect iNOS Fig. 4 . Effect of ESH on NO production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 µg/mL of LPS only or with LPS plus various concentrations (12.5, 25, 50, 100 µg/mL) of ESH for 24 h. NO production was determined by the Griess reagent method. The data represent the mean ± SD of triplicate experiments. *P < 0.05, **P < 0.01 versus LPS alone. Fig. 5 . Effect of ESH on PGE 2 production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 µg/mL of LPS only or with LPS plus various concentrations (12.5, 25, 50, 100 µg/mL) of ESH for 24 h. PGE 2 produced and released into the culture medium was measured by ELISA. The data represent the mean ± SD of triplicate experiments. *P < 0.05, **P < 0.01 versus LPS alone. Fig. 6 . Effect of ESH on the activation of iNOS and COX-2 in LPS-stimulated RAW264.7 cells. RAW264.7 cells (5.0×10 5 cells/mL) were stimulated with LPS (1 µg/mL) and the ESH (12.5, 25, 50, 100 µg/mL) for 24 h. Whole-cell lysates (25 µg) were prepared and the protein was subjected to 8% SDS-PAGE; expression of iNOS, COX-2, and β-actin were determined by Western blotting.
and COX-2 proteins or mRNA in unstimulated RAW 264.7 cells. However, iNOS and COX-2 protein levels were markedly upregulated by LPS, an effect that was inhibited by co-treatment with ESH (Fig. 6) . On the Fig. 7 . Effect of ESH on the TNF-α (a), IL-6 (b) and IL-1β (c) production in LPS-stimulated RAW264.7 cells. The cells were stimulated with 1 µg/mL of LPS only or with LPS plus various concentrations (12.5, 25, 50, 100 µg/mL) of ESH for 24 h. TNF-α, IL-6 and IL-1β produced and released into the culture medium was assayed by ELISA method. The data represent the mean ± SD of triplicate experiments. *P < 0.05, **P < 0.01 versus LPS alone.
other hand, ESH did not affect the expression of β-actin, a housekeeping gene. In general, these results indicate that the inhibitory effects of ESH on LPSinduced NO and PGE 2 production are the result of the suppression of iNOS and COX-2.
Since TNF-α, IL-6 and IL-1β are also inflammatory mediators, their productions were measured in the culture medium of LPS-stimulated RAW264.7 cells following treatment with ESH. Consistent with the attenuated LPS-induced protein expression of iNOS and COX-2, co-incubation of cells with 12.5, 25, 50, or 100 µg/mL of ESH prior to LPS treatment caused a significant (P < 0.05 or P < 0.01) and dose-dependent decrease in the release of TNF-α, IL-6 and IL-1β (Fig. 7) . Fig. 8 . Effects of ESH on the degradation of IκB-α in LPS stimulated RAW264.7 cells. RAW264.7 cells (1.0×10 6 cells/mL) were stimulated with LPS (1 µg/mL) in the presence of ESH (12.5, 25, 50, 100 µg/mL) or PDTC (25 µM) for 15 min. Whole cell lysates (30 µg) were prepared and the protein was subjected to 12% SDS-PAGE; expression of IκB-α and β-actin were determined by Western blotting. β-Actin served as a loading control. Fig. 9 . Effects of ESH on the activation of phospho-NF-κB p65 and phospho-NF-κB p50 in LPS-stimulated RAW264.7 cells. RAW264.7 cells (1.0 × 10 6 cells/mL) were stimulated with LPS (1 µg/mL) in the presence of ESH (12.5, 25, 50, 100 µg/mL) or PDTC (40 µM) for 10 min. Whole cell lysates (30 µg) were prepared and the protein level was subjected to 12% SDS-PAGE, and expression of NF-κB and β-actin were determined by Western blotting. The β-actin antibody served as a loading control.
ESH suppresses the degradation of IκB-α in LPSactivated macrophages
Because activation of NF-κB is critical for induction of both COX-2 and iNOS by LPS or other inflammatory cytokines, we determined whether ESH might be involved in the NF-κB pathway in LPS-activated macrophages. Since it has been well documented that activation of NF-κB correlates with rapid proteolytic degradation of IκB, prevention of IκB degradation was studied as an indication of inhibition of NF-κB activation by ESH. As shown in Figure 8 , LPS induced transient degradation of IκB in RAW cells, whereas ESH prevented degradation of IκB in a dose-dependent manner. These results suggest that inhibition of COX-2 and iNOS expression by ESH occurred via suppression of IκB degradation, thereby preventing NF-κB activation.
Effects of ESH on LPS-induced NF-κB activation, and on the nuclear translocation of p50 and p65 Both p50 and p65 are major components of NF-κB, which is activated by LPS in macrophages. For these reasons, we examined the nuclear translocation of p50 and p65; this was done by immunoblotting. RAW 264.7 cells were incubated with LPS in either the presence or absence of ESH for 1 h. Negligible levels of p50 and p65 proteins were detected in control cell nuclei, but treatment with LPS for 1 h induced the nuclear translocation of both of these. Western blotting revealed that ESH co-treatment dose-dependently attenuated p50 and p65 levels in nuclear fractions (Fig. 9) . β-Actin was used as an internal control in these experiments. Our results suggest that ESH inhibits NF-κB activation by preventing the LPS-induced nuclear translocation of p50 and p65.
Human skin primary irritation test of E. stolonifera To evaluate irritation effects of E. stolonifera extracts on human skin, patch tests were performed. As shown in Table 1 , we did not observe any severe adverse reactions such as erythema, burning or pruritus related to topical treatment with E. stolonifera extracts.
HPLC fingerprint of E. stolonifera ethanol extract According to traditional oriental medicine, the therapeutic actions of herbal medicines are based on the integral interaction of many ingredients. With the development of analytical technology, chromatographic methods can be used to develop fingerprints of traditional oriental medicine and their raw materials. Thus, interest in HPLC fingerprint analysis has increased, not only in Asia, but also in other countries around the world (Zhao et al. 2007; Tao et al. 2008; Yoon et al. 2009; Zhong et al. 2009 ). Therefore, the simple HPLC fingerprint of the E. stolonifera plant was explored in this work. Since phloroglucinol has been reported as the effective anti-inflammatory ingredient in E. stolonifera (Chung et al 2000) , these compounds were used as standard substances. Using the conditions described in the experimental section, phloroglucinol was well resolved from the E. stolonifera crude extract with excellent peak shapes. The phloroglucinol content in the ethanol extract was 4.3 mg/g (Fig. 10) . 
Discussion
Marine natural products provide a rich source of chemical diversity that can be used to design and develop new and potentially useful therapeutic agents. Certain marine products have been reported to exhibit anti-tumor (Bae 2007; Rocha et al. 2007 ), antibacterial (González del Val et al. 2001 Devi et al. 2008) , and anti-inflammatory effects Khan et al. 2008) . Various seaweeds have traditionally been used in oriental folk medicine to treat skin diseases. E. stolonifera is an active, oriental medicine used to treat a variety of inflammatory diseases. Despite its legacy, the pharmacological effects of E. stolonifera have not been fully explored. The present study was undertaken to elucidate the pharmacological and biological effects of E. stolonifera on the production of inflammatory mediators in macrophages. We showed that E. stolonifera suppressed the production of NO, PGE 2 , TNF-α, IL-6, and IL-1β in LPS-stimulated RAW264.7 cells. NO and PGE 2 , which are produced by iNOS and COX-2, respectively, have been implicated as important mediators in endotoxemia and inflammatory conditions. NF-κB is known to play a critical role in the regulation of cell survival genes and to coordinate the expression of pro-inflammatory enzymes and cytokines. Hence, we considered that the inhibitory effects of ESH on the production of NO, PGE 2 , TNF-α, IL-1β, and IL-6 probably occurred via the NF-κB signaling pathway. Accordingly, we confirmed an inhibited expression of iNOS, COX-2, TNF-α, IL-6, and IL-1β by examining the translocation and phosphorylation of p50 and p65. Our results suggest that the translocation and phosphorylation of p50 and p65 is inhibited by ESH in a dosedependent manner. NF-κB (a heterodimer of p65 and p50) is located in the cytoplasm and bound to IκB-α as an inactive complex. The phosphorylation and subsequent degradation of IκB-α involves its dissociation from the complex, thereby producing activated NF-κB. In the present study, we found that the translocation of NF-κB was dose-dependently inhibited by ESH, and the phosphorylation and degradation of IκB-α required for p50 and p65 activation were abolished in cells treated with ESH. Based on these results, we believe that ESH may have inhibited the LPS-stimulated expression of iNOS and COX-2 genes by blocking NF-κB activation. However, we cannot exclude the inhibition of other transcription factors as a possible factor. Finally, to test the application of E. stolonifera extracts as cosmetic materials, we performed primary skin irritation tests on human skin. E. stolonifera extracts did not induce any severe adverse reactions in the human skin irritation tests. Considering these results, we suggest that E. stolonifera extracts be considered as possible anti-inflammatory candidates for topical application. Further research is required to purify and identify the active principles in this fraction as well as to determine its anti-inflammatory properties against skin diseases, such as acne and atopic dermatitis.
